1. Walgreens Boots Alliance terminated its $9.4 billion merger with Rite Aid, and will instead pay Rite Aid $5.18 billion for half of its stores. (WSJ)
2. Biogen appointed Catherine Steele as SVP of corporate affairs, effective July 17. Steele was most recently global head of communications and patient affairs at Novartis. (The Pharma Letter)
3. The FDA said it is taking new measures to drive competition among prescription drugs by publishing a list of branded drugs without approved generics, as well as implementing a new policy to accelerate reviews of generic drugs where there is little competition. (Stat)
4. Genome sequencing of healthy adults could raise their risk of rare disease or cancer-related genetic mutations, a new study found. (Science Recorder)
5. The number of patients aged 60 and older making emergency room visits for shingles fell by nearly 40% as a result of them getting vaccinations, according to a new study. (Reuters)
